Skip to main content
Signal8

Mortenson Mark

SEC insider (Form 3/4/5 filer). CIK 0001835427. Chief Science Officer at Clene Inc. (CLNN). 9 reported Form 4/5 transactions since Sep 2024; latest on Oct 20, 2026. Located in SALT LAKE CITY, UT.

Companies Mortenson Mark has filed insider reports for

  • Clene Inc. (CLNN): Officer, Chief Science Officer
Mortenson Mark profile photo

Mortenson Mark

CIK: 0001835427

Transaction Breakdown

Open Market Buys (P)1 (11.1%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)8 (88.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Clene Inc. logo
CLNN

Clene Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

  • Clene Inc. logo
    CLNN

    Clene Inc.

    Oct 20, 2026
    Award

    stock option

    Direct
    30K shares-
  • Clene Inc. logo
    CLNN

    Clene Inc.

    Jun 11, 2026
    Award

    stock option

    Direct
    45K shares-
  • Clene Inc. logo
    CLNN

    Clene Inc.

    Jan 22, 2026
    Award

    stock option

    Direct
    75K shares-
  • Clene Inc. logo
    CLNN

    Clene Inc.

    Sep 25, 2025
    Award

    stock option

    Direct
    40K shares-
  • Clene Inc. logo
    CLNN

    Clene Inc.

    Sep 25, 2025
    Award

    stock option

    Direct
    40K shares-
  • Clene Inc. logo
    CLNN

    Clene Inc.

    Sep 18, 2025
    Award

    stock option

    Direct
    10K shares-
  • Clene Inc. logo
    CLNN

    Clene Inc.

    Feb 24, 2025
    Award

    Stock Options (Right to buy)

    Direct
    40K shares-
  • Clene Inc. logo
    CLNN

    Clene Inc.

    Sep 30, 2024
    Award

    Warrants (Right to buy)

    Direct
    20.5K shares at avg. $0.13-
  • Clene Inc. logo
    CLNN

    Clene Inc.

    Sep 30, 2024
    Purchase
    Direct
    20.5K shares at avg. $4.75$97K

1-9 of 9